Sandoz

Sandoz, a Pharmaceutical Preparation Manufacturing company based in Switzerland, reported its total greenhouse gas emissions for 2025 as approximately 2.195 billion kg CO2e. This includes about 60.3 million kg CO2e from Scope 1 emissions, approximately 121.9 million kg CO2e from Scope 2 (market-based) emissions, and roughly 2.013 billion kg CO2e from Scope 3 emissions.

For 2024, Sandoz's total emissions were about 2.245 billion kg CO2e. This comprised approximately 73.5 million kg CO2e from Scope 1, around 142.8 million kg CO2e from Scope 2 (market-based), and roughly 2.028 billion kg CO2e from Scope 3 emissions.

In 2023, the company's total emissions stood at approximately 2.260 billion kg CO2e, with Scope 1 emissions at about 86.2 million kg CO2e, Scope 2 (market-based) emissions at around 122.3 million kg CO2e, and Scope 3 emissions at roughly 2.052 billion kg CO2e.

Sandoz has set several climate commitments and targets:

• Near-term Net Zero: The company aims to reduce its Scope 1 and Scope 2 emissions to "near zero" by 2025.
• Absolute Reduction Targets: Sandoz is committed to reducing its Scope 1 emissions by 30% and its Scope 2 emissions by 30% by 2030, both from a 2020 baseline.
• SBTi Targets: Sandoz Group AG, as the source organization for SBTi data, commits to reducing absolute Scope 1 and 2 GHG emissions by 63.0% by 2035 from a 2024 base year. This target is classified as consistent with reductions required to keep warming to 1.5°C. Furthermore, Sandoz Group AG commits that 79.0% of its suppliers, by emissions covering purchased goods and services, capital goods, and upstream transportation and distribution, will have science-based targets by 2030.
• Long-term Net Zero: Sandoz has also committed to working towards achieving net zero emissions by 2050 across all scopes.